NO20002702L - Tienopyrimidiner - Google Patents

Tienopyrimidiner

Info

Publication number
NO20002702L
NO20002702L NO20002702A NO20002702A NO20002702L NO 20002702 L NO20002702 L NO 20002702L NO 20002702 A NO20002702 A NO 20002702A NO 20002702 A NO20002702 A NO 20002702A NO 20002702 L NO20002702 L NO 20002702L
Authority
NO
Norway
Prior art keywords
thienopyrimidine
tienopyrimidines
phosphodiesterase
inhibition
therapy
Prior art date
Application number
NO20002702A
Other languages
English (en)
Other versions
NO20002702D0 (no
Inventor
Rochus Jonas
Franz-Werner Kluxen
Pierre Schelling
Maria Christadler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20002702D0 publication Critical patent/NO20002702D0/no
Publication of NO20002702L publication Critical patent/NO20002702L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Tienopyrimidiner med formel (l) (l) samt deres fysiologisk akseptable salter,, hvor R1, R2, R3, R4, X og n har de i krav l angitte betydninger, utviser en fosfodiesterase V-hemming og kan anvendes til behandling av sykdom- mer i hjerte- og blodomløpssystemet, og til behandling og/eller terapi av potensforstyrrelser.
NO20002702A 1997-11-28 2000-05-26 Tienopyrimidiner NO20002702L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752952A DE19752952A1 (de) 1997-11-28 1997-11-28 Thienopyrimidine
PCT/EP1998/007436 WO1999028325A1 (de) 1997-11-28 1998-11-19 Thienopyrimidine

Publications (2)

Publication Number Publication Date
NO20002702D0 NO20002702D0 (no) 2000-05-26
NO20002702L true NO20002702L (no) 2000-05-26

Family

ID=7850200

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002702A NO20002702L (no) 1997-11-28 2000-05-26 Tienopyrimidiner

Country Status (24)

Country Link
US (2) US6420368B1 (no)
EP (1) EP1036078B1 (no)
JP (1) JP4314341B2 (no)
KR (1) KR20010032445A (no)
CN (1) CN1138780C (no)
AR (1) AR010962A1 (no)
AT (1) ATE361926T1 (no)
AU (1) AU742433B2 (no)
BR (1) BR9815409A (no)
CA (1) CA2311922C (no)
CO (1) CO4980884A1 (no)
CZ (1) CZ291068B6 (no)
DE (2) DE19752952A1 (no)
ES (1) ES2285796T3 (no)
HK (1) HK1038924A1 (no)
HU (1) HUP0100488A3 (no)
ID (1) ID24571A (no)
NO (1) NO20002702L (no)
PL (1) PL341156A1 (no)
RU (1) RU2217431C2 (no)
SK (1) SK7772000A3 (no)
TW (1) TW472059B (no)
WO (1) WO1999028325A1 (no)
ZA (1) ZA9810845B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
WO2000059912A1 (en) * 1999-03-30 2000-10-12 Nippon Soda Co., Ltd. Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE19942474A1 (de) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine
AU2001255849B8 (en) 2000-04-19 2006-04-27 Lilly Icos, Llc. PDE-V inhibitors for treatment of Parkinson's Disease
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10031584A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10042997A1 (de) * 2000-09-01 2002-03-14 Merck Patent Gmbh Thienopyrimidine
CA2423981A1 (en) * 2000-09-29 2003-03-28 Kimiko Ichikawa Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE10058663A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Thienopyrimidinen
BR0116255A (pt) * 2000-12-19 2003-12-30 Merck Patent Gmbh Formulação farmacêutica compreendendo tienopirimidinas e antitrombóticos, antagonistas de cálcio, prostaglandinas e derivados de prostaglandina (1)
DE10064994A1 (de) * 2000-12-23 2002-07-04 Merck Patent Gmbh Sulfamidothienopyrimidine
DE10103647A1 (de) 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
MXPA03006717A (es) * 2001-01-31 2003-10-24 Merck Patent Gmbh Formulacion farmaceutica que comprende pirazolo (4,3-d) pirimidinas y nitratos o tienopirimidinas y nitratos.
US6849638B2 (en) * 2001-04-30 2005-02-01 Bayer Pharmaceuticals Corporation 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditions
DE10148883A1 (de) 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
EP1620437B1 (en) 2003-04-29 2009-06-17 Pfizer Limited 5,7-diaminopyrazolo¬4,3-d pyrimidines useful in the traetment of hypertension
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
CA2562251C (en) 2004-04-07 2009-04-28 Pfizer Inc. Pyrazolo'4,3-d pyrimidines
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
ES2259892B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
ES2259891B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
EP2734530A1 (en) 2011-07-19 2014-05-28 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN109297923A (zh) * 2018-09-19 2019-02-01 南通出入境检验检疫局检验检疫综合技术中心 纺织品中微量含氟整理剂的测定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE245666C (no)
DD245666A1 (de) * 1985-09-20 1987-05-13 Univ Halle Wittenberg Verfahren zur herstellung von 4-aminosubstituierten thieno 2,3-d-pyrimidin-2-ylessigsaeureestern
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine

Also Published As

Publication number Publication date
EP1036078A1 (de) 2000-09-20
NO20002702D0 (no) 2000-05-26
JP4314341B2 (ja) 2009-08-12
AU1962599A (en) 1999-06-16
ATE361926T1 (de) 2007-06-15
DE19752952A1 (de) 1999-06-02
KR20010032445A (ko) 2001-04-25
CA2311922A1 (en) 1999-06-10
JP2001525325A (ja) 2001-12-11
HK1038924A1 (zh) 2002-04-04
RU2217431C2 (ru) 2003-11-27
TW472059B (en) 2002-01-11
HUP0100488A3 (en) 2003-03-28
US6495554B2 (en) 2002-12-17
HUP0100488A2 (hu) 2001-09-28
PL341156A1 (en) 2001-03-26
CZ291068B6 (cs) 2002-12-11
US20020132818A1 (en) 2002-09-19
EP1036078B1 (de) 2007-05-09
ZA9810845B (en) 1999-05-26
AU742433B2 (en) 2002-01-03
US6420368B1 (en) 2002-07-16
ES2285796T3 (es) 2007-11-16
CO4980884A1 (es) 2000-11-27
WO1999028325A1 (de) 1999-06-10
SK7772000A3 (en) 2000-12-11
CZ20001962A3 (cs) 2002-01-16
CN1138780C (zh) 2004-02-18
AR010962A1 (es) 2000-07-12
ID24571A (id) 2000-07-27
DE59814003D1 (en) 2007-06-21
CN1306534A (zh) 2001-08-01
BR9815409A (pt) 2000-10-24
CA2311922C (en) 2009-09-29

Similar Documents

Publication Publication Date Title
NO20002702L (no) Tienopyrimidiner
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
GEP20043303B (en) Polycycloalkylpurines as Adenosine Receptor Antagonists
CA2263561A1 (en) Thienopyrimidines
NO984081L (no) Pyrimido[5,4-d]pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremtilling derav
UA48946C2 (uk) Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування
NO20021083L (no) Pyrazolo[4,3-d]pyrimidiner
NO992821L (no) Ketobenzamider som calpain-inhibitorer
MY103352A (en) Piperazinyl-heterocyclic compounds
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
MY107157A (en) Quinuclidine derivatives.
CA2268886A1 (en) Aminothiophenecarboxamides
BG101289A (en) Pyrimido/5,4-d/pyrimidines, medicamentous forms containing them, their application and method for their preparation
GEP20063920B (en) Alpha-(n-sulphonamido) acetamide derivatives as beta-amyloid inhibitors
TW225532B (no)
NO991761L (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
DK1107973T3 (da) Hidtil ukendte thieno(2,3-D)pyrimidindioner, fremgangsmåde til deres fremstilling og anvendelse deraf i terapi
MY115211A (en) Novel amino acid derivatives, their preparation and use
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
DE50211929D1 (en) Pyrimidinderivate
GEP20043267B (en) Adenosine Receptor Antagonists, Methods of Making and Using the Same
MY121864A (en) Condensed thienopyrimidines with phosphodiesterase-v inhibiting action.
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
RU94039284A (ru) Производные пиперазина, способ их получения, фармкомпозиция и ее использование
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application